Personalized brain stimulation for depression
Part of Mental health clinical trials.
This trial tests a new way of delivering a non-invasive brain stimulation treatment called iTBS for depression. The treatment is personalized based on brain scans, and the study aims to see if it can help reduce depressive symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You have been diagnosed with major depressive disorder (also called clinical depression).
- You must be right-handed.
- Your depression symptoms must be at least moderate in severity.
- If you take antidepressants, your medication dose must have been stable for at least 4 weeks before the study starts.
- You must be able to have an MRI brain scan and the brain stimulation treatment safely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new form of brain stimulation called iTBS (a type of repetitive transcranial magnetic stimulation) that is personalized for each person, compared to a sham (inactive) treatment. It aims to see if this personalized approach can safely reduce symptoms of depression.
This trial tests a new type of brain stimulation called theta-burst stimulation to see if it helps treat depression. It is for people aged 18-50 who are currently experiencing a major depressive episode and are on a stable antidepressant regimen.
This study uses brain imaging to guide a noninvasive treatment called transcranial magnetic stimulation (TMS) for people with depression. It aims to see if tailoring the stimulation to each person's brain can improve symptoms.
This study tests an accelerated form of iTBS (a non-invasive brain stimulation technique) for depression that hasn't improved with antidepressant medications. The goal is to help people with major depression who haven't responded adequately to at least one antidepressant drug.
This trial tests a new type of non-invasive brain stimulation that uses gentle electrical fields to target areas of the brain linked to mood. It aims to help people with moderate to severe depression who haven't responded well to other treatments.
This study tests a new type of brain stimulation that uses gentle electrical fields to target the area of the brain linked to emotions. It may help reduce depression symptoms without the side effects of medications.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.